James Butterfield
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
James Butterfield has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Keith Sweitzer
From the Division of Plastic Surgery, Department of Surgery, University of Rochester, Rochester, NY
3 shared publications - Derek E. Bell
From the Division of Plastic Surgery, Department of Surgery, University of Rochester, Rochester, NY
2 shared publications - Julia Tomtschik
From the Division of Plastic Surgery, Department of Surgery, University of Rochester, Rochester, NY
2 shared publications - Adam Visca
Division of Cardiology, Clinical Cardiovascular Research Center, School of Medicine and Dentistry University of Rochester Rochester New York USA
1 shared publication - Clinton S. Morrison
Department of Plastic Surgery, University of Rochester Medical Center, Rochester, NY, USA
1 shared publication Cody Fowler
From the Division of Plastic Surgery, Department of Surgery, University of Rochester, Rochester, NY
1 shared publication
Latest Publications
- 4 August 2025
- Published by SAGE Publications in HAND
- Vol. 21 (6) , 874-888
Parsonage-Turner Syndrome Following COVID-19 Exposures: A Systematic Review
Background: Parsonage-Turner syndrome (PTS) is an uncommon neuropathy classically characterized by acute onset shoulder pain followed by muscle weakness and usually eventual resolution. In the post-COVID-19 era with large portions of the population experiencing viral infection and vaccination, multiple case reports of PTS surfaced in medical literature, with only 1 case report in hand literature. Methods: A systematic review was performed using PubMed, Embase, Scopus, Web of Science, and Google Scholar to identify all reported cases of PTS related to COVID-19 infection or vaccination. Trends in diagnostic modalities and treatment options were recorded. Results: Thirty-two reports on 54 patients were identified detailing PTS cases following COVID-19 vaccination, and 21 reports on 26 patients following COVID-19 infection. Patients presented an average of 9.5 days following vaccination versus 18.8 days postinfection. Magnetic resonance imaging (MRI) was performed on 82.5% of patients, with the most common findings being normal, hourglass-like constrictions, intramuscular edema on T2-weighted images, and enlargement of regional lymph nodes. Seventy-nine percent (79%) of patients had nerve conductive study (NCS) and electromyography (EMG) performed an average of 6.6 weeks following musculoskeletal symptom onset. Conclusions: As more patients are routinely vaccinated against and/or contract COVID-19, an increase of these patients presenting to hand clinics is possible. Electrodiagnostic studies and MRI may best be obtained 2 and 3 weeks, respectively, after symptom onset. In addition, repeat EMG/NCX should be obtained 9 to 12 months after symptom onset to assess if surgical interventions are indicated. Hand surgeons should be prepared to diagnose and institute therapies to optimize recovery.
- 4 August 2025
- Published by SAGE Publications in HAND
- Vol. 21 (6) , 874-888
Parsonage-Turner Syndrome Following COVID-19 Exposures: A Systematic Review
Background: Parsonage-Turner syndrome (PTS) is an uncommon neuropathy classically characterized by acute onset shoulder pain followed by muscle weakness and usually eventual resolution. In the post-COVID-19 era with large portions of the population experiencing viral infection and vaccination, multiple case reports of PTS surfaced in medical literature, with only 1 case report in hand literature. Methods: A systematic review was performed using PubMed, Embase, Scopus, Web of Science, and Google Scholar to identify all reported cases of PTS related to COVID-19 infection or vaccination. Trends in diagnostic modalities and treatment options were recorded. Results: Thirty-two reports on 54 patients were identified detailing PTS cases following COVID-19 vaccination, and 21 reports on 26 patients following COVID-19 infection. Patients presented an average of 9.5 days following vaccination versus 18.8 days postinfection. Magnetic resonance imaging (MRI) was performed on 82.5% of patients, with the most common findings being normal, hourglass-like constrictions, intramuscular edema on T2-weighted images, and enlargement of regional lymph nodes. Seventy-nine percent (79%) of patients had nerve conductive study (NCS) and electromyography (EMG) performed an average of 6.6 weeks following musculoskeletal symptom onset. Conclusions: As more patients are routinely vaccinated against and/or contract COVID-19, an increase of these patients presenting to hand clinics is possible. Electrodiagnostic studies and MRI may best be obtained 2 and 3 weeks, respectively, after symptom onset. In addition, repeat EMG/NCX should be obtained 9 to 12 months after symptom onset to assess if surgical interventions are indicated. Hand surgeons should be prepared to diagnose and institute therapies to optimize recovery.
- 1 April 2024
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 92 (4S) , S200-S203
Plastic Surgery Involvement With Surgical Management of Infected Ventricular Assist Devices Decreased Lifetime Return to Operating Room and 90-Day Infectious Complications
Background The use of left ventricular assist devices (LVADs) for patients with end-stage cardiac failure awaiting heart transplantation has become increasingly common. However, ventricular assist device–related infections remain a major problem complicating their long-term use. Retrospective review has previously shown a decrease in lifetime return to operating room (RTOR) with no change in 90-day complications when a muscle or omental flap is used for coverage after washout for infection. We wished to determine if early plastic surgery intervention led to a decreased length of stay for these patients. Methods Patients with LVAD readmitted for LVAD infection at a single institution from 2008 to 2021 were identified using a preexisting database. Patients were followed retrospectively for an average of 3.2 years. Patient demographics, preoperative diagnosis/disease state, type of ventricular assist device inserted, postoperative day of ventricular assist device infection onset, definitive device coverage, timing of coverage procedure after the initial washout for infection, type of flap used for coverage, 90-day complications after definitive coverage, and lifetime return to operating room for infection were reviewed. Comparison analysis with χ2 and analysis of variance testing was used to analyze outcomes. Results Of 568 patients admitted with an LVAD infection, 104 underwent operative debridement and closure by plastic and reconstructive surgery (PRS) or cardiothoracic surgery (CTS). Fifty-three underwent PRS closure, and 51 underwent CTS closure. There was an increased incidence of diabetes among the PRS group (P < 0.001); otherwise, there was no difference in baseline characteristics. There was increased RTOR over a lifetime with CTS closure compared with PRS (P = 0.03) and increased 90-day risk of infection (P = 0.007). Patients with PRS closure had an increased risk of postoperative hematoma (P = 046). Plastic and reconstructive surgery was typically consulted on hospital day 10. Both PRS and CTS closure patients were discharged on postoperative day 7, on average (P = 0.542). Conclusions Plastic surgery involvement with surgical decision making and closure of infected LVAD devices has a decrease in lifetime RTOR and decreased 90-day complications related to infections. There may be a benefit to earlier PRS consultation for coverage assessment.
- 1 April 2024
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 92 (4S) , S200-S203
Plastic Surgery Involvement With Surgical Management of Infected Ventricular Assist Devices Decreased Lifetime Return to Operating Room and 90-Day Infectious Complications
Background The use of left ventricular assist devices (LVADs) for patients with end-stage cardiac failure awaiting heart transplantation has become increasingly common. However, ventricular assist device–related infections remain a major problem complicating their long-term use. Retrospective review has previously shown a decrease in lifetime return to operating room (RTOR) with no change in 90-day complications when a muscle or omental flap is used for coverage after washout for infection. We wished to determine if early plastic surgery intervention led to a decreased length of stay for these patients. Methods Patients with LVAD readmitted for LVAD infection at a single institution from 2008 to 2021 were identified using a preexisting database. Patients were followed retrospectively for an average of 3.2 years. Patient demographics, preoperative diagnosis/disease state, type of ventricular assist device inserted, postoperative day of ventricular assist device infection onset, definitive device coverage, timing of coverage procedure after the initial washout for infection, type of flap used for coverage, 90-day complications after definitive coverage, and lifetime return to operating room for infection were reviewed. Comparison analysis with χ2 and analysis of variance testing was used to analyze outcomes. Results Of 568 patients admitted with an LVAD infection, 104 underwent operative debridement and closure by plastic and reconstructive surgery (PRS) or cardiothoracic surgery (CTS). Fifty-three underwent PRS closure, and 51 underwent CTS closure. There was an increased incidence of diabetes among the PRS group (P < 0.001); otherwise, there was no difference in baseline characteristics. There was increased RTOR over a lifetime with CTS closure compared with PRS (P = 0.03) and increased 90-day risk of infection (P = 0.007). Patients with PRS closure had an increased risk of postoperative hematoma (P = 046). Plastic and reconstructive surgery was typically consulted on hospital day 10. Both PRS and CTS closure patients were discharged on postoperative day 7, on average (P = 0.542). Conclusions Plastic surgery involvement with surgical decision making and closure of infected LVAD devices has a decrease in lifetime RTOR and decreased 90-day complications related to infections. There may be a benefit to earlier PRS consultation for coverage assessment.
- 1 April 2024
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 92 (4S) , S101-S104
Superiorly Based Posterior Pharyngeal Flaps
Background Pharyngeal flap (PF) surgery is effective at improving velopharyngeal sufficiency, but historical literature shows a concerning prevalence rate of obstructive sleep apnea (OSA), reported as high as 20%. Our institution has developed a protocol to minimize risk of postoperative obstructive complications and increase safety of PF surgery. We hypothesize that (1) preoperative staged removal of significant adenotonsillar tissue along with (2) multiview videofluoroscopy to guide patient-specific surgical approach via appropriately sized PFs can result in excellent speech outcomes while limiting occurrence of OSA. Methods This was a retrospective chart review of all patients with velopharyngeal insufficiency (VPI) (aged 2–20 years) seen at the University of Rochester from 2015 to 2022 undergoing PF surgery to correct VPI. Nasopharyngoscopy was used for surgical planning and airway evaluation. Patients with tonsillar and adenoid hypertrophy underwent staged adenotonsillectomy at least 2 months before PF. Multiview videofluoroscopy was used to identify anatomic causes of VPI and to determine PF width. Patients underwent polysomnography and speech evaluation before and at least 6 months after PF surgery. Results Forty-one children aged 8.5 ± 4.1 years (range, 4 to 18 years) who underwent posterior PF surgery for VPI were identified. This included 10 patients with 22q11.2 deletion and 4 patients with Pierre Robin sequence. Thirty-nine patients had both pre- and postoperative speech data and underwent both a pre- and postoperative sleep study. Polysomnography showed no significant difference in obstructive apnea-hypopnea index after posterior PF surgery (obstructive apnea-hypopnea index preop, 1.3 ± 1.2 events per hour; postop, 1.7 ± 2.1 events per hour; P = 0.111). Significant improvements in speech outcome were seen in patients who underwent PF (modified Pittsburgh score preop, 11.52 ± 1.37; postop, 1.09 ± 2.35; P < 0.05). Conclusions Use of preoperative staged adenotonsillectomy as well as patient-specific PF dimensions results in effective resolution of VPI and a low risk of OSA.
- 1 April 2024
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 92 (4S) , S101-S104
Superiorly Based Posterior Pharyngeal Flaps
Background Pharyngeal flap (PF) surgery is effective at improving velopharyngeal sufficiency, but historical literature shows a concerning prevalence rate of obstructive sleep apnea (OSA), reported as high as 20%. Our institution has developed a protocol to minimize risk of postoperative obstructive complications and increase safety of PF surgery. We hypothesize that (1) preoperative staged removal of significant adenotonsillar tissue along with (2) multiview videofluoroscopy to guide patient-specific surgical approach via appropriately sized PFs can result in excellent speech outcomes while limiting occurrence of OSA. Methods This was a retrospective chart review of all patients with velopharyngeal insufficiency (VPI) (aged 2–20 years) seen at the University of Rochester from 2015 to 2022 undergoing PF surgery to correct VPI. Nasopharyngoscopy was used for surgical planning and airway evaluation. Patients with tonsillar and adenoid hypertrophy underwent staged adenotonsillectomy at least 2 months before PF. Multiview videofluoroscopy was used to identify anatomic causes of VPI and to determine PF width. Patients underwent polysomnography and speech evaluation before and at least 6 months after PF surgery. Results Forty-one children aged 8.5 ± 4.1 years (range, 4 to 18 years) who underwent posterior PF surgery for VPI were identified. This included 10 patients with 22q11.2 deletion and 4 patients with Pierre Robin sequence. Thirty-nine patients had both pre- and postoperative speech data and underwent both a pre- and postoperative sleep study. Polysomnography showed no significant difference in obstructive apnea-hypopnea index after posterior PF surgery (obstructive apnea-hypopnea index preop, 1.3 ± 1.2 events per hour; postop, 1.7 ± 2.1 events per hour; P = 0.111). Significant improvements in speech outcome were seen in patients who underwent PF (modified Pittsburgh score preop, 11.52 ± 1.37; postop, 1.09 ± 2.35; P < 0.05). Conclusions Use of preoperative staged adenotonsillectomy as well as patient-specific PF dimensions results in effective resolution of VPI and a low risk of OSA.
- 21 December 2022
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 90 (6S) , S552-S555
Flap Coverage of Infected Ventricular Assist Devices Influences Patient Outcomes
Background: The use of left ventricular assist devices (LVADs) for patients with end-stage cardiac failure awaiting heart transplantation has become increasingly common. However, ventricular assist device–related infections remain a major problem complicating their long-term use. Poor data exist to determine how to manage these infections after operative debridement. Methods: Patients who underwent insertion of a ventricular assist device and had a subsequent readmission for LVAD infection at the University of Rochester Medical Center from 2012 to 2022 were identified through accessing the medical records archives of the hospital. Patients were followed retrospectively for an average of 3.2 years. Patient demographics, preoperative diagnosis/disease state, type of ventricular assist device inserted, postoperative day of ventricular assist device infection onset, infectious organism identified at initial washout, infectious organism identified at time of definitive device coverage, timing of coverage procedure after the initial washout for infection, type of flap used for coverage, 90-day complications after definitive coverage, and lifetime return to operating room for infection were reviewed. Comparison analysis with a χ2 test was used to analyze outcomes. Results: Of 568 patients admitted with an LVAD-related infection 117 underwent operative debridement. Of these, 34 underwent primary closure, 31 underwent closure with secondary intention (negative pressure wound therapy with split thickness skin grafting), and 52 were closed with a flap (pectoralis, omental, latissimus, or vertical rectus abdominus musculocutaneous flap). There was a statistically significant higher incidence of return to the operating room (RTOR) for infection over a lifetime with primary closure compared with secondary intention and flap reconstruction (P = 0.01, 0.02), but no difference in 90-day complications (P = 0.76, P = 0.58). Eighty-three patients had a positive culture upon definitive coverage with 24 having a postsurgical complication, 15 of which required lifetime RTOR for infection. Thirty four were closed with negative cultures with 9 having a complication and 4 requiring RTOR for infection. This was not statistically significant for complications or RTOR (P = 0.79, 0.40). Culture data were further substratified into bacterial cultures (n = 73) versus fungal cultures (n = 10), and there was no statistically significant difference between these compared with complications or RTOR (P = 0.40, 0.39). Conclusions: Coverage of infected LVADs with locoregional flaps or allowing to granulate using wound vac therapy has a decreased lifetime RTOR for future infections for these patients without increase in 90-day complications. Timing of RTOR should not be impacted by positive cultures provided there is healthy granulation tissue in the wound.
- 21 December 2022
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 90 (6S) , S552-S555
Flap Coverage of Infected Ventricular Assist Devices Influences Patient Outcomes
Background: The use of left ventricular assist devices (LVADs) for patients with end-stage cardiac failure awaiting heart transplantation has become increasingly common. However, ventricular assist device–related infections remain a major problem complicating their long-term use. Poor data exist to determine how to manage these infections after operative debridement. Methods: Patients who underwent insertion of a ventricular assist device and had a subsequent readmission for LVAD infection at the University of Rochester Medical Center from 2012 to 2022 were identified through accessing the medical records archives of the hospital. Patients were followed retrospectively for an average of 3.2 years. Patient demographics, preoperative diagnosis/disease state, type of ventricular assist device inserted, postoperative day of ventricular assist device infection onset, infectious organism identified at initial washout, infectious organism identified at time of definitive device coverage, timing of coverage procedure after the initial washout for infection, type of flap used for coverage, 90-day complications after definitive coverage, and lifetime return to operating room for infection were reviewed. Comparison analysis with a χ2 test was used to analyze outcomes. Results: Of 568 patients admitted with an LVAD-related infection 117 underwent operative debridement. Of these, 34 underwent primary closure, 31 underwent closure with secondary intention (negative pressure wound therapy with split thickness skin grafting), and 52 were closed with a flap (pectoralis, omental, latissimus, or vertical rectus abdominus musculocutaneous flap). There was a statistically significant higher incidence of return to the operating room (RTOR) for infection over a lifetime with primary closure compared with secondary intention and flap reconstruction (P = 0.01, 0.02), but no difference in 90-day complications (P = 0.76, P = 0.58). Eighty-three patients had a positive culture upon definitive coverage with 24 having a postsurgical complication, 15 of which required lifetime RTOR for infection. Thirty four were closed with negative cultures with 9 having a complication and 4 requiring RTOR for infection. This was not statistically significant for complications or RTOR (P = 0.79, 0.40). Culture data were further substratified into bacterial cultures (n = 73) versus fungal cultures (n = 10), and there was no statistically significant difference between these compared with complications or RTOR (P = 0.40, 0.39). Conclusions: Coverage of infected LVADs with locoregional flaps or allowing to granulate using wound vac therapy has a decreased lifetime RTOR for future infections for these patients without increase in 90-day complications. Timing of RTOR should not be impacted by positive cultures provided there is healthy granulation tissue in the wound.